Prevalence of Kaposi Sarcoma-Associated Herpesvirus Compared With Selected Sexually Transmitted Diseases in Adolescents and Young Adults in Rural Rakai District, Uganda

Background Kaposi sarcoma-associated herpesvirus (KSHV) is transmitted by routes such as homosexual intercourse and is associated with HIV infection in industrialized countries. However, there is little information about its transmission in developing countries where Kaposi sarcoma is an endemic disease. Goal To examine KSHV seroprevalence in young adults in a general, rural Ugandan population, and to compare this prevalence with rates of known sexually transmitted infections. Study Design The seroprevalence of KSHV was compared with the epidemiology of sexually transmitted diseases in 523 sexually active subjects aged 15 to 29 years who were randomly selected from a general population cohort in rural Rakai District, Uganda. Participants provided in-home interview data and specimens. Sera were tested for KSHV using immunofluorescence assay and immunoblot for lytically expressed recombinant KSHV ORF65.2. Sera were also tested for HIV type 1, herpes simplex virus type 2, and syphilis. Results The prevalence of KSHV was significantly higher in participants 15 to 19 years compared with older persons 25 to 29 years (45.0% and 36.1%, respectively; adjusted odds ratio, 0.48; 95% CI, 0.28–0.82). In contrast, herpes simplex virus type 2 and HIV type 1 prevalence increased with age. Kaposi sarcoma-associated herpesvirus serostatus was not associated with HIV type 1, syphilis, herpes simplex virus type 2, or number of sexual partners. Homosexual and anal intercourse were reported by less than 1% of participants. Conclusions Kaposi sarcoma-associated herpesvirus does not appear to be a heterosexually transmitted infection in rural Uganda.

[1]  C. Boshoff,et al.  Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. , 1999, The Journal of infectious diseases.

[2]  V. Beral,et al.  Antibodies against human herpesvirus 8 in black South African patients with cancer. , 1999, The New England journal of medicine.

[3]  G. de Thé,et al.  Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa , 1999, International journal of cancer.

[4]  J. Kaldor,et al.  Kaposi's sarcoma-associated herpesvirus: a sexually transmissible infection? , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[5]  C. Kankasa,et al.  Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS. , 1998, The Journal of infectious diseases.

[6]  L. Cuevas,et al.  Prevalence and transmission of Kaposi's sarcoma‐associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents , 1998, International journal of cancer.

[7]  Thomas C. Quinn,et al.  A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda , 1998, AIDS.

[8]  V. Beral,et al.  Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection. , 1998, JAMA.

[9]  L. Bélec,et al.  Enhanced detection of human herpesvirus-8 and cytomegalovirus in semen of HIV-seropositive asymptomatic heterosexual men living in Central Africa. , 1998, AIDS.

[10]  Jeffrey N. Martin,et al.  Sexual transmission and the natural history of human herpesvirus 8 infection. , 1998, The New England journal of medicine.

[11]  C. Boshoff,et al.  Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. , 1998, Journal of the National Cancer Institute.

[12]  D. Cooper,et al.  Risk of Kaposi's sarcoma and oroanal sexual contact. , 1997, American journal of epidemiology.

[13]  R. Greenblatt,et al.  The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. , 1997, JAMA.

[14]  C. Boshoff,et al.  Detection of human herpesvirus 8 DNA in semen from HIV‐infected individuals but not healthy semen donors , 1997, AIDS.

[15]  P. Simmonds,et al.  Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen , 1996, The Lancet.

[16]  J. Phair,et al.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.

[17]  J. Phair,et al.  Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. , 1996, The New England journal of medicine.

[18]  E. Cesarman,et al.  Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae , 1996, Journal of virology.

[19]  P. Moore,et al.  Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.

[20]  V. Beral,et al.  Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS , 1992, The Lancet.